At a Glance
Dosage
oral
| Level | 2C-I | 1B-LSD |
|---|---|---|
| Threshold | 2 mg | 15 µg |
| Light | 5–10 mg | 25–75 µg |
| Common | 10–20 mg | 75–150 µg |
| Strong | 20–30 mg | 150–300 µg |
| Heavy | 30 mg | 300 µg |
Duration
oral
2C-I
oral
Total: 6 hrs – 10 hrsPeak
Afterglow
Onset15 min – 45 min
Come Up45 min – 1.5 hrs
Peak3 hrs – 5 hrs
Offset
Effects
Safety
Interaction: 2C-I + 1B-LSD
No direct interaction data available between these substances. This does not mean the combination is safe.
2C-I — Dangerous Interactions
No dangerous interactions recorded.
1B-LSD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 2C-I and 1B-LSD?
2C-I is classified as a Psychedelic (Substituted phenethylamines) while 1B-LSD is classified as a Psychedelic (Lysergamides). They share 37 effects in common, with 7 effects unique to 2C-I and 42 unique to 1B-LSD.
Is it safe to combine 2C-I and 1B-LSD?
There is no direct interaction data available for combining 2C-I and 1B-LSD. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 2C-I or 1B-LSD?
At common doses via oral, 2C-I is typically dosed at 10–20 mg while 1B-LSD is dosed at 75–150 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.